ATE445604T1 - Neue 2,6-diaminopyridin-3-on-derivate - Google Patents

Neue 2,6-diaminopyridin-3-on-derivate

Info

Publication number
ATE445604T1
ATE445604T1 AT05759728T AT05759728T ATE445604T1 AT E445604 T1 ATE445604 T1 AT E445604T1 AT 05759728 T AT05759728 T AT 05759728T AT 05759728 T AT05759728 T AT 05759728T AT E445604 T1 ATE445604 T1 AT E445604T1
Authority
AT
Austria
Prior art keywords
diaminopyridine
derivatives
new
Prior art date
Application number
AT05759728T
Other languages
English (en)
Inventor
David Bartkovitz
Xin-Jie Chu
Allen Lovey
Peter Wovkulich
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35385535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE445604(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE445604T1 publication Critical patent/ATE445604T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Mobile Radio Communication Systems (AREA)
AT05759728T 2004-07-15 2005-07-08 Neue 2,6-diaminopyridin-3-on-derivate ATE445604T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58812204P 2004-07-15 2004-07-15
PCT/EP2005/007432 WO2006005548A1 (en) 2004-07-15 2005-07-08 Novel 2,6-diaminopyridine-3-one derivatives

Publications (1)

Publication Number Publication Date
ATE445604T1 true ATE445604T1 (de) 2009-10-15

Family

ID=35385535

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05759728T ATE445604T1 (de) 2004-07-15 2005-07-08 Neue 2,6-diaminopyridin-3-on-derivate

Country Status (16)

Country Link
US (1) US7423051B2 (de)
EP (1) EP1771420B1 (de)
JP (1) JP2008505955A (de)
KR (1) KR100853973B1 (de)
CN (1) CN1980893B (de)
AR (1) AR050427A1 (de)
AT (1) ATE445604T1 (de)
AU (1) AU2005261899A1 (de)
BR (1) BRPI0513366A (de)
CA (1) CA2573604A1 (de)
DE (1) DE602005017152D1 (de)
ES (1) ES2330765T3 (de)
MX (1) MX2007000574A (de)
RU (1) RU2385866C2 (de)
TW (1) TW200612929A (de)
WO (1) WO2006005548A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007137196A2 (en) * 2006-05-19 2007-11-29 Threshold Pharmaceuticals, Inc. Tubulin binding anti cancer compounds and prodrugs thereof
EP1900727A1 (de) * 2006-08-30 2008-03-19 Cellzome Ag Aminopyridinderivate als Kinase-Inhibitoren
US8017607B2 (en) 2009-10-14 2011-09-13 Hoffmann-La Roche Inc. N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
JP2023507028A (ja) * 2019-12-20 2023-02-20 エボポイント、バイオサイエンシズ、カンパニー、リミテッド 複素環式化合物とその医薬組成物、調製方法、中間体及び使用
US20250009745A1 (en) * 2021-02-05 2025-01-09 Shanghai Qilu Pharmaceutical Research And Development Centre Ltd. Cdk inhibitor
CN113117077B (zh) * 2021-03-04 2022-08-09 西南民族大学 一种用于肿瘤联合治疗的铂基单原子纳米酶及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL342447A1 (en) 1997-10-27 2001-06-04 Agouron Pharma Substituted 4-amino thiazol-2-yl compounds as inhibitors of cyclin-dependent kinases
US6262096B1 (en) * 1997-11-12 2001-07-17 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
WO2000076980A1 (en) * 1999-06-10 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
NZ516872A (en) 1999-09-15 2003-10-31 Warner Lambert Co Pteridinones as kinase inhibitors
BR0015718A (pt) 1999-11-22 2002-07-23 Warner Lambert Co Quinazolinas e seu uso para inibição de enzimas de cinase dependente de ciclina
BR0110302A (pt) 2000-04-18 2003-01-14 Agouron Pharma Compostos de pirazol para inibição de proteìnas cinase, sal e pró-droga farmaceuticamente aceitável, metabólito farmaceuticamente ativo ou sal farmaceuticamente aceitável de metabólito, composição farmacêutica, método de tratamento de condição doentia em mamìferos mediada pela atividade de proteìna cinase, método de modulação ou inibição da atividade de um receptor de proteìna cinase
FR2832148B1 (fr) * 2001-11-14 2004-05-21 Oreal Nouvelles bases d'oxydation 2,5-diaminopyridine utiles pour la teinture des fibres keratiniques
MXPA05008878A (es) 2003-02-21 2005-10-05 Pfizer Derivados de aminotiazol sustituidos con cicloalquilo que contiene n y composiciones farmaceuticas para inhibir la proliferacion celular, y metodos para su uso.
EP1689394A4 (de) 2003-11-19 2009-06-03 Janssen Pharmaceutica Nv AMðNOSUBSTITUIERTE PYRIDINYLMETHANON-VERBINDUNGEN ZUR BEHANDLUNG VON KINASE-STÖRUNGEN

Also Published As

Publication number Publication date
KR20070028539A (ko) 2007-03-12
EP1771420A1 (de) 2007-04-11
US20060014708A1 (en) 2006-01-19
AR050427A1 (es) 2006-10-25
DE602005017152D1 (de) 2009-11-26
US7423051B2 (en) 2008-09-09
AU2005261899A1 (en) 2006-01-19
BRPI0513366A (pt) 2008-05-06
CA2573604A1 (en) 2006-01-19
EP1771420B1 (de) 2009-10-14
ES2330765T3 (es) 2009-12-15
TW200612929A (en) 2006-05-01
WO2006005548A1 (en) 2006-01-19
JP2008505955A (ja) 2008-02-28
RU2385866C2 (ru) 2010-04-10
RU2007105558A (ru) 2008-08-20
KR100853973B1 (ko) 2008-08-25
CN1980893A (zh) 2007-06-13
MX2007000574A (es) 2007-03-07
CN1980893B (zh) 2011-01-19

Similar Documents

Publication Publication Date Title
HUS1900034I1 (hu) 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok
DE60328671D1 (de) Neue aminobenzamidderivate
DK1824856T3 (da) 2,4 (4,6)-pyrimidinderivater
NO20053161D0 (no) Mikrobedrepende sammensetning.
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
DE602005022897D1 (de) Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen
DK1725553T3 (da) Tetrahydropyridoindolderivater
ATE540935T1 (de) Chinazolinderivate
DK1761541T3 (da) Pyrrazolo-pyrimidin-derivater
ATE506362T1 (de) 1-aza-bicycloä3.3.1ünonane
EP1786831A4 (de) Alanin-2,3-aminomutasen
ATE421506T1 (de) Neue benzimidazolderivate
ATE417830T1 (de) Sulfonylbenzimidazolderivate
ATE387440T1 (de) Neue 4-benzylidenpiperidinderivate
NL1030382A1 (nl) Gesubstitueerde N-sulfonylaminobenzyl-2-fenoxyaceetamide verbindingen.
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
DE602005023145D1 (de) Neue androgene
ATE425167T1 (de) Neue pyridothienopyrimidinderivate
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
DK1740574T3 (da) 4-amino-5-cyanopyrimidinderivater
ATE445604T1 (de) Neue 2,6-diaminopyridin-3-on-derivate
DE50309081D1 (de) Neue diketopyrrolopyrrolpigmente
EP1799223A4 (de) Arylthiobenzylpiperidin-derivate
ES1058958Y (es) Mastil perfeccionado.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties